Effects of Vitamin E on Transfusion Requirements in TransfusionDependent Beta-Thalassemia Patients
Duangdee Trangsuwan; Malai Wongchanchailert; Ladda Mo-suwan; Thirachit Chotsampancharoen; Ruchaneekorn Kalpravidh; Penjamaporn Apiromruck; Thanom Chu-ngan; Sudarat Khotchawan · 2018 · Journal of Health Science and Medical Research (JHSMR)
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract
Objective: To evaluate the volume of blood transfusion requirements as well as hemolytic and oxidative biochemical variables in transfusion-dependent β-thalassemia patients supplemented with vitamin E. Material and Methods: A prospective, double-blind, randomized, placebo-controlled, crossover study was undertaken between December, 2012 and September, 2014 in the Pediatric Clinic of Songklanagarind Hospital. The participants were β-thalassemia major and Hb E/β-thalassemia patients aged between 5 and 18 years. A random allocation sequence was generated to receiving either 6 months of vitamin E
Abstract by Duangdee Trangsuwan; Malai Wongchanchailert; Ladda Mo-suwan; Thirachit Chotsampancharoen; Ruchaneekorn Kalpravidh; Penjamaporn Apiromruck; Thanom Chu-ngan; Sudarat Khotchawan, Journal of Health Science and Medical Research (JHSMR) (2018) — licensed CC BY 4.0.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke
Negative / Null Result ReportDuodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Negative / Null Result ReportStenting versus Endarterectomy for Treatment of Carotid-Artery Stenosis
Negative / Null Result ReportEffects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Replication FailureA Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma
Negative / Null Result ReportSpironolactone for Heart Failure with Preserved Ejection Fraction
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: DOAJ · DOI 10.31584/jhsmr.2018.36.3.19